When government bodies and other organizations consider cases or policy decisions that affect consumers or competition, the FTC may offer insight and expertise to decision makers by filing an advocacy letter. To find a specific filing, use the filters on this page.
Displaying 301 - 320 of 867
FTC Comment to the Food and Drug Administration Concerning Response to Citizen Petition by IVAX Pharmaceuticals Relating to Generic Drug Application
Date
Matter Number
V050006
Related Release
FTC Comment Before the Â鶹´«Ã½ Reserve Board Concerning Proposed Amendments to Regulation E
Date
Matter Number
V050001
Related Release
FTC Staff Comment to the Honorable Doug Matayo Concerning Arkansas H.B. 2286 and the Fairness to Contact Lens Consumers Act and Contact Lens Rule
Date
Matter Number
V040026
Related Release
FTC Comment Before the Department of Energy Concerning the Designation of National Interest Electric Transmission Bottlenecks
Date
Matter Number
V040028
Related Release
FTC Staff Comment Before the Food and Drug Administration Concerning Nutrient Claims
Date
Matter Number
V040020
FTC Comment Before the Â鶹´«Ã½ Energy Regulatory Commission Concerning Solicitation Processes for Public Utilities; Merchant Generation Assets
Date
Matter Number
V040022
Related Release
FTC Staff Comment to the Honorable Gene DeRossett Concerning Michigan H.B. 4757, the Petroleum Marketing Stabilization Act
Date
Matter Number
V040019
Related Release
FTC Staff Comment Before the Food and Drug Administration Concerning Consumer-Directed Promotion
Date
Matter Number
V040016
Displaying 301 - 320 of 867